Carolina Pola
Chief Executive Officer Stab Therapeutics
Seminars
Thursday 26th February 2026
STAb-T Cells: Bridging Cell Therapy & Bispecific Antibodies for Sustained Antitumour Immunity
2:00 pm
- Explore how STAb-T cells combine the precision of cell therapy with the versatility of bispecific antibodies to achieve durable tumour control
- Highlight emerging preclinical data demonstrating their potential to enhance targeting breadth and induce sustained responses
Wednesday 25th February 2026
Industry Leaders Fireside Chat: Navigating Europe’s Cell Therapy Landscape Amid Investment Pressures, Novel Approaches, & Opportunities for Patient Access
8:30 am
- Discuss how investment headwinds are shaping company strategies and what it takes to sustain progress in Europe
- Highlight the most promising scientific advances, including novel indications, armouring strategies, and in-vivo approaches
- Explore how patient access models, from point-of-care manufacturing to evolving reimbursement pathways, can unlock future growth
